At a glance
ClinicalIndex Comparison RecordN/ACompleted· 224 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer
In Brief
An observational study for Breast Cancer. Completed, enrolled 224 participants across 20 sites.
Detailed Summary
The purpose of this study is to investigate if sentinel lymph node biopsy is a reliable staging tool for breast cancer patients planned for neoadjuvant chemotherapy (=before breast surgery) and if, in that case, it is safe to omit axillary lymph node dissection if the sentinel lymph node is free of metastasis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesSweden
CollaboratorsSwedish Breast Cancer Group
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2010
First PostedJan 2014
Primary CompletionDec 2015
TodayJul 2026
First PostedJan 9, 2014
Enrollment StartOct 1, 2010
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 12.5 years ago